Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins

Ahmi Ben-Yehudah, Haya Lorberboum-Galski*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Abstract

Tumor-associated antigens (TAAs) have been identified mainly to determine cancer prognosis. In the past few years, TAAs have been used in the development of treatment modalities such as tumor vaccination. This review describes an additional application of TAAs: as a target for specific antitumor treatment. Since TAAs are overexpressed on the tumor cell surface, they can be targeted to deliver drugs directly to cancer cells. One such delivery system exploits chimeric proteins. Chimeric proteins are a class of targeted molecules designed to recognize and specifically destroy cells that overexpress specific receptors. These molecules, designed and constructed by gene fusion techniques, comprise both cell-targeting and cell-killing moieties. The authors' laboratory has developed a number of chimeric proteins using gonadotropin-releasing hormone (GnRH) as the targeting moiety. These chimeras recognize a GnRH binding site that is expressed on adenocarcinoma cells. GnRH was fused to a large number of killing moieties, including bacterial and human proapoptotic proteins. All GnRH-based chimeric proteins selectively killed adenocarcinoma cells both in vitro and in vivo. Utilizing chimeric proteins for targeted therapy represents a new and exciting therapeutic modality for the treatment of cancer in humans.

Original languageAmerican English
Pages (from-to)151-161
Number of pages11
JournalExpert Review of Anticancer Therapy
Volume4
Issue number1
DOIs
StatePublished - Feb 2004

Keywords

  • Apoptosis
  • Associated antigens
  • Cancer treatment
  • Chimeric proteins
  • Gonadotropin-releasing hormone
  • Gonadotropin-releasing hormone receptor
  • Tumor

Fingerprint

Dive into the research topics of 'Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins'. Together they form a unique fingerprint.

Cite this